Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cherie Rondeau"'
Autor:
Maximilian Merz, Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W. Block, Hemn Mohammadpour, Paul K. Wallace, Joseph Tario, Jesse Luce, Sean T. Glenn, Prashant Singh, Megan M. Herr, Theresa Hahn, Mehmet Samur, Nikhil Munshi, Song Liu, Philip L. McCarthy, Jens Hillengass
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Osteolytic lesions (OL) are frequent in multiple myeloma (MM), but are poorly understood. Here, the authors characterise OLs in MM patient samples using single-cell RNA-seq, revealing genes that are specifically regulated in OL compared to random bon
Externí odkaz:
https://doaj.org/article/f796828f91bf49deafc2d56948663af8
Autor:
Paul K. Wallace, Lei Wei, Philip L. McCarthy, Theresa Hahn, Almuth Maria Anni Merz, Jesse Luce, Qiang Hu, Prashant Singh, Maximilian Merz, Megan M. Herr, Song Liu, Ahmed Belal, Ronald A. Alberico, Joseph D. Tario, AnneMarie W. Block, Cherie Rondeau, Kelvin P. Lee, Hemn Mohammadpour, Sean T. Glenn, Jens Hillengass, Kimberly Celotto, Jie Wang
Publikováno v:
Blood Advances. 7:718-733
Introduction: Therapy and immune mediated processes are associated with clonal evolution in multiple myeloma (MM). In this study, we performed whole-exome sequencing (WES) and single cell RNA sequencing (scRNA-seq) on plasma cells (PC) from bone marr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210082d481787055ba7eb1ec3f09c12d
https://doi.org/10.1182/bloodadvances.2022007457
https://doi.org/10.1182/bloodadvances.2022007457
Autor:
Paul K. Wallace, Joseph D. Tario, Philip L. McCarthy, AnneMarie W. Block, Jens Hillengass, Ahmed Belal, Mehmet Kemal Samur, Cherie Rondeau, Jesse Luce, Maximilian Merz, Hemn Mohammadpour, Theresa Hahn, Lei Wei, Almuth Maria Anni Merz, Sean T. Glenn, Song Liu, Kimberly Celotto, Jie Wang, Nicholas Hutson, Prashant Singh, Megan M. Herr, Qiang Hu, Ronald A. Alberico, Nikhil C. Munshi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Osteolytic lesions (OL) characterize symptomatic multiple myeloma. The mechanisms of how malignant plasma cells (PC) cause OL in one region while others show no signs of bone destruction despite subtotal infiltration remain unknown. We report on a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987e81162b982dcc2696723f9ce336f6
https://doaj.org/article/f796828f91bf49deafc2d56948663af8
https://doaj.org/article/f796828f91bf49deafc2d56948663af8
Autor:
Joseph D. Tario, Lei Wei, David R. Barnidge, Paul K. Wallace, Maximilian Merz, Qiang Hu, Jens Hillengass, AnneMarie W. Block, Sean T. Glenn, Ronald A. Alberico, Kimberly Celotto, Philip L. McCarthy, Jie Wang, Almuth Maria Anni Merz, Hemn Mohammadpour, Jesse Luce, Ahmed Belal, Song Liu, Cherie Rondeau, Prashant Singh
Publikováno v:
Blood. 138:1607-1607
Introduction Malignant plasma cells (PC) in multiple myeloma (MM) are not homogeneously distributed in the bone marrow and spatial genomic heterogeneity is an evolving concept in MM. PC for histopathology, cytogenetic and molecular analyses and minim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d198fbf68f14f1f393c004079584a655
https://doi.org/10.1182/blood-2021-152427
https://doi.org/10.1182/blood-2021-152427
Autor:
Alice Mohr, Francisco J. Hernandez-Ilizaliturri, Cherie Rondeau, M Syta, Swaminathan Padmanabhan Iyer, Megan Menon, Kimberly Celotto, Jeffrey Baron, Ryan Hare, Ian Lund, Seema A. Bhat
Publikováno v:
Journal of Clinical Oncology. 34:e19023-e19023
e19023Background: Adequate cytoreduction with cisplatin-based chemotherapy is commonly used prior to high dose chemotherapy and autologous stem cell support (HDC-ASCS) among R/R aggressive lymphoma...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15817cb18cbc040cfb244ca8e493461c
https://doi.org/10.1200/jco.2016.34.15_suppl.e19023
https://doi.org/10.1200/jco.2016.34.15_suppl.e19023